Menactra Vaccine Information
Menactra® (meningococcal vaccine) is approved for use in people age 2 through 55 years old. Available as an injection, it is given as a single dose and provides protection against invasive meningococcal diseases, such as bacterial meningitis. The vaccine is made by Sanofi Pasteur, Inc., and is currently not available in generic form.
Although most people tolerate it well, side effects are possible with this product. According to information from clinical studies, the most common side effect of Menactra is pain at the injection site (occurring in up to 59.2 percent of people). Other common side effects include fatigue, headache, and malaise.
There is only one recommended dose for this vaccine, regardless of age or weight. At this time, a booster dose is not recommended, although this could change in the future.
(For more information on this vaccine, click Menactra. This full-length article offers more detailed information on what this product is used for, how it works, potential drug interactions, and more.)